Patents by Inventor Moshe Hosen

Moshe Hosen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR PROGNOSIS OF OVARIAN CANCER
    Publication number: 20170073775
    Abstract: Described herein are compositions and methods for the prediction of the prognosis of ovarian cancer subjects. The present invention farther provides methods for distinguishing between histological subtypes of ovarian cancer tumors, and also methods and compositions liar the treatment or prevention of ovarian cancer. Specifically the invention relates to microRNA molecules associated with said methods and compositions, as well as various nucleic acid molecules relating thereto or derived therefrom.
    Type: Application
    Filed: November 29, 2016
    Publication date: March 16, 2017
    Inventors: Moshe Hosen, Gila Lithwick Yanai, Ram Eitan
  • Compositions and methods for prognosis of ovarian cancer
    Patent number: 9540695
    Abstract: Described herein are compositions and methods for the prediction of the prognosis of ovarian cancer subjects. The present invention further provides methods for distinguishing between histological subtypes of ovarian cancer tumors, and also methods and compositions for the treatment or prevention of ovarian cancer. Specifically the invention relates to microRNA molecules associated with said methods and compositions, as well as various nucleic acid molecules relating thereto or derived therefrom.
    Type: Grant
    Filed: May 19, 2009
    Date of Patent: January 10, 2017
    Assignees: Rosetta Genomics Ltd., MOR Research Applications
    Inventors: Moshe Hosen, Gila Lithwick Yanai, Ram Eitan
  • COMPOSITIONS AND METHODS FOR PROGNOSIS OF OVARIAN CANCER
    Publication number: 20110105596
    Abstract: Described herein are compositions and methods for the prediction of the prognosis of ovarian cancer subjects. The present invention further provides methods for distinguishing between histological subtypes of ovarian cancer tumors, and also methods and compositions for the treatment or prevention of ovarian cancer. Specifically the invention relates to microRNA molecules associated with said methods and compositions, as well as various nucleic acid molecules relating thereto or derived therefrom.
    Type: Application
    Filed: May 19, 2009
    Publication date: May 5, 2011
    Inventors: Moshe Hosen, Gila Lithwick Yanai, Ram Eitan